🤩 New snapshot summary on pneumococcal vaccination in patients with reduced kidney function! doi.org/10.1093/ckj/sf… Dustin Le is the YNP author. Prepared by Lauren Floyd. ERA - European Renal Association CKJ

This #organdonation week, join BTPT and Trainee Representatives in in Organ Donation (TROD) for quick fire summaries and updates across the range of organ transplantation! 26th September 5-6pm Sign up now! app.medall.org/event-listings… The Herrick Society BTS

Outstanding editorial from Muthu Vaduganathan GLP-1 receptor agonists in heart failure - The Lancet thelancet.com/journals/lance…

💕 This 2024 #organdonationweek, BTPT join with TRODs to bring STATE OF THE ART: TRANSPLANTATION An insight into the amazing work being performed in donation and transplant across the UK 📝 Signup here: app.medall.org/event-listings…

New in NEJM Evidence! Original Article by Jeffrey Ha et al.: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease eviden.cc/3z2CLzM Sunil Badve Min Jun Swapnil Hiremath @[email protected] Daniel Coyne Suetonia Palmer David C Wheeler Vlado Perkovic The George Institute for Global Health UNSW Medicine & Health

🌟 Are you a young nephrologist looking to unlock the benefits of the Young Nephrologists' Platform? 🎥Tune in to our interview with the YNP Chair-Elect, Safak Mirioglu! 🤝 Learn how you can collaborate and thrive within the YNP of ERA. Full interview 👉 bit.ly/3Gf1XDJ

As we head towards #organdonationweek, great to see work in JAMA showing peri-op mortality in living kidney donors declined substantially in the last decade, and is now fewer than 1 event per 10000 donations. jamanetwork.com/journals/jama/…

📢 Join us for the 3rd YPNN-ESPN – YNP of ERA joint e-seminar : *#IgA #nephropathy, from #childhood to #adulthood including transition* with expert speakers and a patient perspective. 📅 September 6, 2024, 4 PM (CEST) Register now 👉 bit.ly/3YY9alG

GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in Circulation for #ESCCongress ahajournals.org/doi/abs/10.116…

Swe the amazing Effects of Semaglutide on Heart Failure Outcomes in Diabetes and CKD sciencedirect.com/science/articl… Steno Diabetes Center Copenhagen

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial academic.oup.com/eurheartj/arti…

The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30. You can download the public review draft and share comments via the feedback survey on the KDIGO

Pooled data from ~15,000 pts in 4-RCTs examining the relationship b/w NT-proBNP, kidney function & outcomes in HFpEF Data which calls into question proposals for higher NT-proBNP references ranges in people with CKD #Simpub in JACC-HF for #ESCCongress sciencedirect.com/science/articl…

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in NEJM nejm.org/doi/full/10.10…

Scott Solomon presenting the primary results of the FINEARTS-HF trial at #ESCCongress - finerenone in patients with HFpEF PEP: total HF events or CV death SEP: total HF events, KCCQ, NHYA class, renal endpoint Vital status known in +99% of patients at end of follow up

The FINEHEART Program results, presented by Muthu Vaduganathan now #simpub in Nature medicine nature.com/articles/s4159… #ESCCongress

Whole pop UK linked data on >230,000 ppl with HF from Robert Fletcher at #ESCCongress - Ppl with CKD remain undertreated for HF despite being at 🔼 risk - CKD contributes 2x to 🏥/☠️ than any other comorbidity - Major opportunities to improve pop health In press, The Lancet Public Health

Congratulations to ⁦Will Herrington⁩ on his inaugural professorial lecture!

Please let us know your thoughts on priority areas for data driven research related to kidney and cardiovascular disease.

Great day for #IgAN patients everywhere 🎉 ir.travere.com/news-releases/…